Podcasts about Imaging

Most medical imaging happens after a symptom, injury, or abnormal test gives a clinician a reason to look. But what changes if imaging becomes a more routine measurement, creating a record of the body before something goes wrong?In this episode of Next Level, Mike Haney talks with Dr. Daniel Durand, chief medical officer at Prenuvo, about whole-body MRI as a test case for a broader shift from episodic medicine toward longitudinal health data. Whole-body MRI is controversial, and Durand is clearly an advocate. The conversation takes the skepticism seriously, then asks a larger question: as measurement gets cheaper, more frequent, and increasingly visible to patients themselves, how should medicine decide what is worth knowing?Free course: Improve your metabolic healthGet our free email course on how glucose, nutrition, exercise, sleep, and measurement can help you build habits that support better energy and long-term health: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://levels.link/wnl⁠What We Cover:How X-rays, CT scans, ultrasound, and MRI differ, and why radiation matters when you start thinking about repeated imagingWhat whole-body MRI sees well, and where CT, colonoscopy, or blood-based approaches may still be betterThe concerns around incidental findings, overdiagnosis, anxiety, and unnecessary follow-up, and Durand's response to themWhat the current cancer-detection evidence for whole-body MRI does, and does not, establishWhy having prior scans could help distinguish a stable abnormality from something genuinely newHow faster scans and AI interpretation could eventually connect imaging with genomic, proteomic, and other health data

Adrian Mendes, Chief Executive Officer at Perimeter Medical,  has developed a platform that uses AI and optical coherence tormography (OCT) imaging to provide surgeons with real-time visualization of tumor margins during breast cancer surgery.  By scanning while the patient is still in the operating room the platform enables surgeons to identify cancerous cells at the margins and remove addiional tissue, eliminating the need for delayed pathology review and possible additional surgery. This technology benefits all stakeholders- the patients avoid repeat surgery, surgeons see a higher success rate, hospitals optimize operating room utilization, and payers have reduced costs.  Adrian explains, "So fundamentally, the challenge that we see out there in cancer surgery, and specifically in breast cancer surgery, is that there's a very high rate of patients who have to come back in for a second surgery. For breast cancer, it's about one in every four to one in every five patients who go through breast cancer surgery who have to come back again because a surgeon unfortunately wasn't able to remove all the cancer. And so we help them with that." "What we do is we have a product that has an imaging system in it that uses a unique modality type of imaging that has very high resolution. And with that, the surgeons can, in real time, look within the margin of the tumor and inspect it and then make a decision on whether they need to take more tissue right there in that first surgery because they see some cancerous cells in that margin or not." "Fundamentally, the goal of a surgery, a cancer surgery, the way it's judged as being successful or not, is if they're able to remove the tumor and have a few millimeters thick of clean margin, no cancerous cells within that two-millimeter margin, and then that would be considered a successful surgery. And it's very hard to do. And not being able to do that is what leads to that very high re-operation rate." #PerimeterMedical #BreastCancer #Healthcare #ArtificialIntelligence #AIinHealthcare #DigitalHealth #MedTech #CancerCare #MedicalImaging #BreastCancerSurgery #SurgicalOncology #AIinMedicine #MedTech #ORInnovation #HealthcareAI #FDAApproved #PatientOutcomes perimetermed.com Download the transcript here

Adrian Mendes, Chief Executive Officer at Perimeter Medical,  has developed a platform that uses AI and optical coherence tormography (OCT) imaging to provide surgeons with real-time visualization of tumor margins during breast cancer surgery.  By scanning while the patient is still in the operating room the platform enables surgeons to identify cancerous cells at the margins and remove addiional tissue, eliminating the need for delayed pathology review and possible additional surgery. This technology benefits all stakeholders- the patients avoid repeat surgery, surgeons see a higher success rate, hospitals optimize operating room utilization, and payers have reduced costs.  Adrian explains, "So fundamentally, the challenge that we see out there in cancer surgery, and specifically in breast cancer surgery, is that there's a very high rate of patients who have to come back in for a second surgery. For breast cancer, it's about one in every four to one in every five patients who go through breast cancer surgery who have to come back again because a surgeon unfortunately wasn't able to remove all the cancer. And so we help them with that." "What we do is we have a product that has an imaging system in it that uses a unique modality type of imaging that has very high resolution. And with that, the surgeons can, in real time, look within the margin of the tumor and inspect it and then make a decision on whether they need to take more tissue right there in that first surgery because they see some cancerous cells in that margin or not." "Fundamentally, the goal of a surgery, a cancer surgery, the way it's judged as being successful or not, is if they're able to remove the tumor and have a few millimeters thick of clean margin, no cancerous cells within that two-millimeter margin, and then that would be considered a successful surgery. And it's very hard to do. And not being able to do that is what leads to that very high re-operation rate." #PerimeterMedical #BreastCancer #Healthcare #ArtificialIntelligence #AIinHealthcare #DigitalHealth #MedTech #CancerCare #MedicalImaging #BreastCancerSurgery #SurgicalOncology #AIinMedicine #MedTech #ORInnovation #HealthcareAI #FDAApproved #PatientOutcomes perimetermed.com  Listen to the podcast here

https://www.contrast-connect.com/blog-post/how-to-scale-an-imaging-center-adding-capacity-without-adding-on-site-physiciansYour scanner might be idle for reasons that have nothing to do with equipment or space. What's really blocking growth at imaging centers, and how are directors quietly fixing it without hiring more radiologists? ContrastConnect City: Las Vegas Address: Las vegas Website: https://www.contrast-connect.com/

We have another episode on remote sensing, and my guest is Mark Keremedjiev from a startup called Orbital Sentry. Mark tell us why persistent monitoring from geosynchronous orbit makes sense for use cases including wildfires.   0:00 — Introduction 1:11 — Welcome & Elevator Pitch:" 2:13 — The LEO Data Access Problem 4:29 — Wildfires & a Dynamic World 6:05 — XPRIZE for Wildfire Detection 8:29 — LEO Limitations 11:23 — The GEO Solution 13:40 — Costs & Improvements 16:00 — Declining Costs 17:20 — The Spatial Challenge 21:09 — Temporal Resolution 22:34 — Defense Applications 27:09 — Data Strategy 31:48 — Go-to-Market 37:27 — Sensor Technology & In-Space Compute 41:45 — 10-Year Vision & Favorite Science-Fiction  

The combination of photon-counting CT and low-keV VMI has the potential to aid bladder cancer local stage Anna Lo Verde, MD, discusses the prospective study by Wang et al. exploring this combination for detecting muscle invasion. Full article: Photon-Counting CT With Low-keV Virtual Monoenergetic Images for Detecting Muscle Invasion in Bladder Cancer: A Prospective Study

Master Alzheimer's disease (AD) imaging protocols and amyloid-related imaging abnormality (ARIA) monitoring to optimize patient care with amyloid-targeting therapies (ATTs). Credit available for this activity expires: 09/25/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/aligning-amyloid-targeting-therapy-imaging-protocols-us-2026a1000ygm?ecd=bdc_podcast_libsyn_mscpedu

Exodus 19:1-9; Psalm 8; Acts 1:1-11; Luke 7:1-10 The Eighteenth Sunday after Pentecost - Imaging God: Authority Father Christian Ruch

OpenAI has reportedly bought Glass Imaging – the ex-Apple team behind the iPhone's Portrait Mode – for the camera in its first hardware device. Meanwhile, a former cinematographer turned carpenter has got his Digital Bolex rebuild working: original Kodak CCD, Raspberry Pi 5, V-mount battery, wooden box. Big tech vs. one-man camera build – plus the Sony FX5 delay in Japan, DJI SDR Transmission 2, the OrBrella crowdfunding start and lots of IBC gear. This Episode is Sponsored by Hollyland (00:15:06) ► Check out the Pyro S: http://cined.co/nImvmn   Topics and Chapters in this Episode:   (00:00:00) Intro   (00:02:12) OpenAI Reportedly Buys Glass Imaging for the Camera in Its First Hardware Device https://www.cined.com/openai-reportedly-buys-glass-imaging-for-the-camera-in-its-first-hardware-device-ai-image-processing-from-an-ex-apple-team/   (00:15:58) David Bross Digital Bolex Rebuild Reaches Working Prototype https://www.cined.com/david-bross-digital-bolex-rebuild-reaches-working-prototype-kodak-ccd-raspberry-pi-5-free-loaner-units-planned/   (00:29:42) Blackmagic Camera for iOS 3.5 Released https://www.cined.com/blackmagic-camera-for-ios-3-5-released-iphone-18-pro-support-variable-aperture-control-prores-to-pro-video-storage/   (00:33:49) Sony FX5 Delayed to Late October or Later in Japan https://www.cined.com/sony-fx5-delayed-to-late-october-or-later-in-japan-dvf-el1-viewfinder-xlr-h2-handle-and-launch-campaign-also-affected/   (00:38:42) Sony DP7 and DP5 Explained https://www.cined.com/sony-dp7-and-dp5-explained-native-cinema-line-camera-control-2000-nit-calibrated-panels-third-party-wireless/   (00:44:50) Tilta EVF Extension Kit for Sony FX5 Detailed https://www.cined.com/tilta-evf-extension-kit-for-sony-fx5-detailed-cage-base-plate-nucleus-autofocus-integration-xlr-adapter-in-development/   (00:47:58) DJI SDR Transmission 2 Launched https://www.cined.com/dji-sdr-transmission-2-launched-dci-4k60-10-bit-hdr-switchable-tx-rx-transceivers-4km-range/   (00:55:39) SmallRig x CineD OrBrella Light Introduced https://www.cined.com/smallrig-x-cined-orbrella-light-introduced-60w-umbrella-style-light-that-deploys-in-five-seconds/   (01:01:41) Atomos Shinobi 7 II & Shogun AV-19M Introduced https://www.cined.com/atomos-shinobi-7-ii-shogun-av-19m-introduced-first-look/   (01:05:55) Accsoon CineView M7 Series Updated https://www.cined.com/accsoon-cineview-m7-series-updated-expanded-camera-control-vertical-ui-user-built-android-apps/   (01:09:55) Insta360 Luna Ultra Firmware Update Released https://www.cined.com/insta360-luna-ultra-firmware-update-released-15x-zoom-concert-stage-mode-4k-vertical-video-and-a-450mm-telephoto-lens/   (01:13:33) Cartoni HyperRoll Explained https://www.cined.com/cartoni-hyperroll-explained-skate-wheels-for-any-camera-cage-nato-rail-mounting-lockable-wheel-angles/   (01:22:38) Vocas EL-40 Eyepiece Loupe for the Sony PXW-Z300 Introduced https://www.cined.com/vocas-el-40-eyepiece-loupe-for-the-sony-pxw-z300-introduced-magnetic-tool-free-mount-flip-up-design-swappable-camera-attachments/   (01:24:13) NIPROS VEGA-R Fiber Adapter for RED KOMODO Introduced https://www.cined.com/nipros-vega-r-fiber-adapter-for-red-komodo-introduced-zero-latency-12g-sdi-analog-optical-transmission-1gbe-control/   (01:26:10) FUJIFILM VF-GFXC2 Viewfinder for the GFX ETERNA 55 Explained https://www.cined.com/fujifilm-vf-gfxc2-viewfinder-for-the-gfx-eterna-55-explained-native-43-oled-two-display-modes-single-cable-connection/   (01:31:32) Libec Q30B and Q50B Explained https://www.cined.com/libec-q30b-and-q50b-explained-quick-deploy-ring-45kg-payload-dust-proof-spreader-locks/   (01:34:07) Profoto ProPanel 3×2 Accessories Introduced https://www.cined.com/profoto-propanel-3x2-accessories-introduced-6x6ft-snapbag-l-40-snapgrid-s-truss-clamp-kit/   (01:35:15) DigitalFoto THANOS-PROCINE ELITE Camera Stabilizing System Introduced https://www.cined.com/digitalfoto-thanos-procine-elite-camera-stabilizing-system-introduced-30kg-payload-improved-arm-vest-and-more/   (01:36:50) DigitalFoto Battery Handles for DJI Osmo Pocket and Insta360 Luna Introduced https://www.cined.com/digitalfoto-battery-handles-for-dji-osmo-pocket-and-insta360-luna-introduced-5000mah-20w-quick-charge-color-display/   (01:38:40) Rolux Foldable Dual V-Mount Charger Introduced https://www.cined.com/rolux-foldable-dual-v-mount-charger-introduced-100w-usb-c-input-fanless-design-780g/   (01:40:28) CAME-TV Hub Pro Announced https://www.cined.com/came-tv-hub-pro-announced-32-headset-intercom-expansion-xlr-audio-30-hour-battery/   (01:43:38) SIRUI Aurora 15mm f/1.6 and 24mm f/1.4 Full-Frame Autofocus Lenses Unveiled https://www.cined.com/sirui-aurora-15mm-f-1-6-and-24mm-f-1-4-full-frame-autofocus-lenses-unveiled/   (01:44:59) The Secret That Doesn't Matter https://www.cined.com/the-secret-that-doesnt-matter-hitchcocks-macguffin-in-screenwriting-then-and-now/ We hope you enjoyed this episode!

In this episode of the How I Rehab Podcast, we sit down with sports podiatrist Blake Withers to work through a real clinical case: a 19-year-old marathon runner with anterior shin pain and eight weeks to go before race day. Blake Withers is a musculoskeletal podiatrist, University of Newcastle biomechanics lecturer, and PhD candidate researching running injury prevention. He also hosts The Sports Medicine Project podcast (https://podcasts.apple.com/au/podcast/sports-medicine-project/id1608497693) and is a marathon runner himself. Together we work through the full clinical picture, history, red flags, imaging decisions and a week-by-week return-to-run plan covering: Training load and distribution as the biggest driver of bone stress injury How bone stress injury symptoms differ from tendinopathy Differential diagnoses for shin pain — and the one you can't afford to miss Why the anterior tibia is a high-risk site, and how to palpate it properly Imaging pathways: when to choose X-ray, MRI or CT MTSS ("shin splints") vs. bone stress injury — same spectrum, or separate conditions? The three phases of rehab: pain, capacity, and minimum effective dose Progressive reloading and unloading strategies by injury grade Running biomechanics, footwear and gait changes that offload the tibia Want to go deeper on bone stress injury assessment and reloading? Rich Willy, one of the world's leading voices on running injuries, breaks it down step by step in the Bone Stress Injury Reloaded Masterclass, now live on SportsMAP: https://sportsmap.com.au/course/bone-stress-injury-reloaded-the-lower-limb/ Get a free 7-day trial and unlock the entire SportsMAP masterclass library while you're there. Connect with Blake: Instagram: @blakesportspodiatrist Podcast: The Sports Medicine Project Join us at Fast Track the Injured Runner — our annual running injury conference in Melbourne this February. Full details at https://sportsmap.com.au/product/fast-track-the-injured-runner-2027/   https://www.youtube.com/watch?v=Z4NL4Jjqf6M

Cardiology practices are under pressure to deliver high-quality patient care while navigating complex workflows, operational challenges and the realities of running a sustainable practice. In this episode of MedAxiom HeartTalk, host Melanie Lawson, MS, sits down with Patrick O'Keefe of Upbeat Cardiology Solutions who shares how his firsthand experience in the imaging lab shaped his approach to helping practices overcome those challenges, including implementing cardiac PET, streamlining workflows and building solutions that support both patient care and practice success.

In this podcast episode, Dr. Vilanilam discusses “Cerebral Proliferative Angiopathy: Imaging Spectrum and Diagnostic Insights,” by first author Rai.Cerebral proliferative angiopathy is a rare cerebrovascular malformation that can mimic an arteriovenous malformation but has a fundamentally different vascular architecture and underlying physiology. This comprehensive review of 75 studies and 153 patients highlights its characteristic multimodal imaging features, including a diffuse vascular network intermingled with normal brain, absence of a compact nidus or dominant arterial feeders, frequent transdural recruitment, relatively limited early venous drainage, and evidence of chronic hypoperfusion.Dr. Vilanilam reviews the key CT, MRI, perfusion, and angiographic findings that help distinguish cerebral proliferative angiopathy from conventional arteriovenous malformations and other vascular mimics. Recognizing this distinction is critical because normal functioning brain is incorporated within the abnormal vascular network, substantially influencing treatment decisions and emphasizing the importance of accurate imaging diagnosis.Featured Article: Cerebral Proliferative Angiopathy: Imaging Spectrum and Diagnostic Insights

What can you do before surgery to help your body recover better? From protein and strength training to supplements and prehabilitation, which strategies actually make a difference?This week, Dr. Rebecca Knackstedt joins me to break down the science behind surgical recovery, including protein, creatine, supplements, and nutritional deficiencies. We also discuss breast cancer screening, mammograms, MRIs, thermography, and QT imaging.

Matthew Paul Clemons, MD, is a diagnostic radiologist specializing in nuclear medicine and body imaging. He is Head of Nuclear Medicine at Radiology Partners Houston and a rectal and prostate cancer specialist.Whole-body MRI promises a detailed look under the hood—but what can a quick screening scan actually see, miss, and send you chasing? Dr. Paul Clemons explains why a whole-body MRI is a limited study, how incidental findings can lead to further tests, and why standard screening remains the better choice for most people.Expect to learn how MRI creates images and why scan protocols take time, why open MRI systems can have important image-quality limits, how PET/MRI adds functional information, why CT and MRI can be complementary rather than redundant, how radiation and implanted devices factor into decisions, why spine findings do not always match symptoms, when conservative care deserves consideration, and where DEXA versus MRI can be useful for tracking body-composition trends.Episodes you'll enjoy next:#237 — Demystifying Body Composition Testing with Dr Grant Tinsley and Dr Eric Helms: a practical companion discussion on body-composition measurement and its limits.#159 — Advice, Mentorships, Askholes, and Diagnostics: An Interview with Dr. Adam Sumarski: a related conversation on diagnostics and imaging in sports medicine.Episode Timestamps:1:50 Whole-body MRI and preventive screening2:52 How MRI works: magnets, noise, and safety7:05 Open MRI, magnet strength, and image quality9:05 MRI sequences, scan time, and diagnostic protocols11:47 Why whole-body MRI is a limited screen12:46 Incidental findings and downstream testing13:57 High-risk screening, rare genetic conditions, and lung limits17:53 Sensitivity, specificity, and standard screening24:15 PET/MRI and where whole-body imaging has a clinical role27:05 Why MRI and PET/CT systems are expensive to install31:59 MRI safety, implants, and pacemakers36:36 CT versus MRI: why one scan can lead to another38:52 Whole-body CT, radiation, and its limits43:47 Back-pain scans: why an image may not explain symptoms51:44 Physical therapy, surgery, and warning signs58:46 Evaluating evidence for peptides, stem cells, and biologics1:05:47 Choosing an orthopedic surgeon for athletic goals1:15:24 DEXA versus MRI for body-composition trends Get the Daily Fitness Insider newsletter (free): https://www.miketnelson.com/newsletter

Genesis 1:26-31; Colossians 3:1-16; John 1:1-18 The Seventeenth Sunday after Pentecost - Imaging God Father Peter Berg Download

When does a raised troponin become a myocardial infarction? What has happened to “type 2 MI”? And how certain can we be about the diagnosis without imaging? Iain Beardsell introduces Professor Rick Body for a practical guide to the Fifth Universal Definition of Myocardial Infarction. Rick explains the changes in terminology, troponin interpretation and diagnostic criteria, focusing on what they mean for clinicians assessing patients in the emergency department. What Rick covers Primary, secondary and procedure-related MI. The new classification replaces the previous numbered types. Rick explains why primary MI now includes coronary dissection, vasospasm and embolism, alongside atherothrombosis. He also describes how the 30-day window after coronary intervention or bypass surgery defines procedure-related MI. Sex-specific troponin thresholds. The definition explicitly recommends sex-specific upper reference limits. Rick discusses why this matters and encourages clinicians to understand the thresholds used by their own laboratory, rather than assuming every troponin assay works in the same way. A likely diagnosis versus a confirmed diagnosis. Cardiac and coronary imaging take a more prominent role in confirming MI and identifying its cause. This is particularly relevant when considering secondary MI in patients with sepsis, tachyarrhythmia or gastrointestinal haemorrhage. A troponin rise alone does not establish myocardial infarction. Acute and chronic myocardial injury. Rick explores the causes of myocardial injury beyond infarction, including inflammation, haemodynamic stress, catecholamine effects, toxicity and trauma. He also challenges the habit of diagnosing chronic myocardial injury from two similar troponin results during an acute ED attendance, without establishing the patient's stable baseline or investigating the underlying cause. Making sense of the troponin delta. Absolute changes, percentage changes, the starting concentration, time from symptom onset and the interval between samples all influence interpretation. Rick explains why there is no single delta that works for every patient, and why sampling intervals must match the evidence supporting the thresholds being used. STEMI, NSTEMI and occlusive MI. The traditional terminology remains, but the definition recognises important ECG patterns beyond conventional ST elevation. Rick discusses the place of posterior MI, de Winter T waves, Wellens syndrome, the Aslanger pattern and Sgarbossa criteria within this evolving approach. The episode also considers the practical consequences of these changes. More investigation brings additional resource demands, and Rick highlights the uncertainty about whether a more extensive assessment of chronic myocardial injury will improve patient outcomes. More from the accompanying blog Professor Nick Mills, first author of the new definition, adds an important clarification: a working clinical diagnosis can guide initial treatment. Imaging helps identify the cause and improve diagnostic certainty, but unavailable or inappropriate angiography does not prevent a clinical diagnosis. In secondary MI, managing the presenting illness remains the immediate priority. Rick also notes that HEART, T-MACS, EDACS and MI-3 are not addressed in the document. He interprets this as being outside its scope, rather than a change to their use. The post includes Rick's video presentation and details of ADOPT-UDMI, an education, evaluation and research programme inviting clinicians from all specialties to help put the new classification into practice. Read the full post: The Fifth Universal Definition of Myocardial Infarction: What Emergency Clinicians Need to Know Learning from podcasts? If podcasts form part of your CPD, MedPod Learn brings together St Emlyn's and other medical podcasts. Browsing and listening are free. Premium adds listening-time tracking, MCQs, structured reflection prompts and an exportable learning record for CPD and appraisal, with globally adjusted pricing.

Real-world cases illustrate the value of cardiac MRI in this expert panel discussion that also looks at the promise of next-generation contrast agents. Credit available for this activity expires: 9/18/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/cardiac-mri-action-case-based-insights-precision-imaging-2026a1000xnn?ecd=bdc_podcast_libsyn_mscpedu

In this episode, Frank Marchlinski, MD, Deputy Editor of JACC: Clinical Electrophysiology, discusses a study of ventricular tachycardia ablation in patients with active cardiac sarcoidosis. Using integrated FDG-PET and cardiac MRI imaging, the investigators found that VT exit sites were often located in areas of active inflammation, while more proximal circuit sites were associated with scar. Patients in whom only VT exit sites could be identified had substantially higher VT recurrence rates, suggesting that targeting deeper portions of the VT circuit may improve outcomes.

Jason and Nitesh, the co-founders of 28 States Brewing Co. join Herlinda Heras and Daedalus Howell in the studio on Brew Ha Ha today. ProChiller Green will be performing a Proof of Concept test at Hanabi Lager on September 23, 2026, to demonstrate the ProGreen Chiller in a brewery. Visit ProChiller online for more info. 28 States Brewing was founded 11 months ago in San Francisco, named after the 28 states of India. Nitesh comes from home brewing and opening a brewery is a big step. They are making beer with Indian spices and even toasted basmati rice. The name is Desi Gaijin. Daedalus finds that it is subtle and balanced.  +++++Visit Russian River Brewing Co. in Santa Rosa on 4th St. and at their big Windsor location. Check out their website and socials for up-to-dated hours, menus, beers, special events and more. ++++++ Next they taste a Hefeweizen, made on an open fermenter. Nitesh explains that San Francisco has natural bacteria in the air that makes San Francisco sourdough bread special. He fermented this beer using open fermentation so he captures the same local microbes. There is a funk and a savory finish that comes from the bacteria. He will be experimenting with open and closed fermentation. It is called Haryana Weizen. Haryana is Nitesh’s native state. Weizen beer has to be 60% wheat and this is 61%. From the bar to the sales call Jason and Herlinda discover that they both were bartenders before ever working in sales. It’s a great training ground, for learning how to talk to all kinds of people. Jason met Nitesh by simply talking about beer. ******Visit our sponsor Pro Chiller online for all the info about their new CO2-based Pro Green Solutions Chiller.****** Nitesh was home brewing while working in tech. During Covid, when everyone was working at home, he started home brewing with advice from his mentor, Lester Koga of Barebottle Brewing. He started 28 States before he met Jason. Now there are so many flavors in is beer it’s amazing. He describes one called Mango Elaichi Sour flavored with Indian mangoes and cardamom. Herlinda will host a beer cruise from Basel, Switzerland down the Rhein past Strasbourg, France ending in Amsterdam. It will be in November 2027, because these trips are always planned well in advance. There will be local beer tastings all along the way. Imaging coming into port and taking a bike ride while the chefs go shopping in town for fresh bread and delicious foods that the countryside produces. There is a $1000 discount available up to September 30. Email chelsea@cruiseplanners.com to book the cruise and get the early discount.  

JOIN THE FAMILY: The Astrocast | Weekly Astronomy/Astrophotography Podcast | PatreonWELCOME BAAAACK to The EUROCAST! In this weeks episode, guest host Mark Lindley takes The Astrocast to Europe for a trip through Switzerland, the French Alps, and the Vosges Mountains, where online friendships finally become face-to-face conversations.Between missed train stops, passport trouble, cloudy skies, and a shared meal, Mark catches up with Dr. Klaus Schweitzer and Tim from Belgium. There's plenty of astrophotography talk along the way: traveling with camera lenses, remote observatories, processing software, simple star trackers, and knowing when to upgrade your gear.But the moment that makes the trip comes under the stars, when Tim sees the Milky Way for the first time. Mark closes his journey with a personal reflection on loneliness, friendship, and finding your people, followed by his original poem, “Alone Together.”Come for the stars. Stay for the company.Featured guests: Mark Lindley, Dr. Klaus Schweitzer, Tim, and Roo.Field-recording note: Parts of the car conversation have rough audio. To skip ahead to the cottage conversation, jump from 36:05 to 1:16:40.Chapters00:00:00 A first glimpse of the Milky Way — cold open00:00:48 Mark takes the mic: welcome to the Eurocast00:04:20 The friends, the route, and the plan00:09:14 Arriving in Geneva00:12:21 Chamonix and the French Alps00:16:48 Alpine hiking, wildlife, and changing glaciers00:20:42 Sponsor: Dark Dragons Astronomy00:22:29 The Mont Blanc Express and a break in the clouds00:26:26 Lausanne, passport trouble, and travel lessons00:34:53 A missed train stop on the way to the meetup00:39:05 Meeting Dr. Schweitzer and hitting the road00:54:52 Finding time to image and planning for remote skies01:16:40 At the cottage: meet Tim01:22:06 Cooking dinner and talking dark skies01:31:08 Camera lenses versus telescopes01:37:07 Processing software and homemade mounts01:47:54 Building a remote observatory setup01:58:09 Simple star trackers, dithering, and calibration frames02:09:19 Choosing gear, upgrades, and support02:20:32 Learning from the community02:28:49 One-on-one with Tim: photography and finding astronomy02:39:08 Generosity, friendship, and the Astrocast community02:50:21 Imaging together and learning to gather more data02:57:52 Mark shares his Mont Blanc Milky Way image03:03:22 Planning a simple Milky Way setup03:13:10 Finding the joy in less gear03:22:11 Under the Stars: a clearing above the clouds03:24:24 Tim sees the Milky Way for the first time03:29:20 Heading home: Mark reflects on the trip03:38:28 “Alone Together” — a poem by Mark Lindley03:41:13 Roo's closing thanks and epilogue03:43:47 The Astrocast outro songMusic credit“La fille aux cheveux de lin” from Préludes, Book I by Claude Debussy. MIDI performance by Katsuhiro Oguri, rendered using Garritan Steinway; published by Quinn Mason. Sourced from IMSLP, file #280628, licensed under Creative Commons Attribution 3.0. Mixed beneath poetry and closing narration for this episode.✨ Agena Astro |

A strong research question can still fail if the study design cannot answer it. Michael Soulen, MD, and Shudaveep Ganguly, MD, DM, speak with host Amit Gupta, MD, about selecting meaningful outcomes, matching design to the question, avoiding pitfalls of diagnostic accuracy studies, involving statisticians early, and building multidisciplinary trials. Listen to their discussion in episode 3 of The Early Career Researcher's Playbook, an AJR Podcast Series. *Key Takeaways Meaningful Outcomes vs. Surrogates: Technical success and progression-free survival are only surrogate endpoints. Patients and clinicians ultimately care about overall survival and quality of life. Imaging surrogates are notoriously poor predictors of true clinical benefit. Flaws in Diagnostic Accuracy: Relying purely on sensitivity and specificity is problematic if the study population doesn't reflect real-world conditions. Likelihood ratios may provide a realistic indication of a test's clinical impact. Early Statistical Integration: Never treat a statistician as a data calculator at the end of a study. Engaging them during the brainstorming phase ensures feasibility and helps to properly structures your protocol and database. *Chapters  0:00 - Welcome 2:23 - Choosing Meaningful Outcomes 9:28 - RCTs and Real World Limits 18:36 - Diagnostic Study Pitfalls 25:58 - From Accuracy to Impact 28:55 - Statistics Starts Early 37:45 - Making Collaboration Work 47:01 - Quick Fire Playbook 51:04 - Final Advice Follow AJR on Social Media LinkedIn: https://www.linkedin.com/showcase/ajr-radiology/ YouTube: https://www.youtube.com/channel/UCfFAYezkLMxJGMgIJLN0Dpg Instagram: https://www.instagram.com/ajr_radiology/ TikTok: https://www.tiktok.com/@ajr_radiology X: https://x.com/AJR_Radiology BlueSky: https://bsky.app/profile/ajrradiology.bsky.social Threads: https://www.threads.com/@ajr_radiology *These sections were generated using artificial intelligence (Descript and Google Gemini) and then reviewed for accuracy.

What does it mean to truly know a word—and how can biblical language instructors help students learn, retain, and retrieve vocabulary?In this episode of SLA Insights, Dr. Jennifer E. Noonan concludes her vocabulary-acquisition series with a guided recap of episodes 85–95. Explore each topic and watch the individual episodes below.VOCABULARY ACQUISITION SERIES► SLA Insights #85: What Does It Mean to Know a Word?https://youtu.be/rMWO3BfM3_k?si=5A16Vb1Im29ZjHue► SLA Insights #86: Factors That Affect Vocabulary Learning, Part 1https://youtu.be/Egty8HFPTP8?si=sXsf04yRWrNXgRrV► SLA Insights #87: Factors That Affect Vocabulary Learning, Part 2https://youtu.be/a4WqYx0CFZE?si=NBM_t59_Un_bYF-u► SLA Insights #88: Factors That Affect Vocabulary Learning, Part 3https://www.youtube.com/watch?v=L1IJ02lAYE4► SLA Insights #89: Factors That Affect Vocabulary Learning, Part 4https://youtu.be/14iHG1YFmR8?si=kxg9YlSTIynY0cGV► SLA Insights #90: Direct and Indirect Vocabulary Instructionhttps://youtu.be/pWiPyckDFY4?si=2mD-cdKPy0zzKXtG► SLA Insights #91: Vocabulary Flashcardshttps://www.youtube.com/watch?v=A-5M2Df-C3c► SLA Insights #92: Imaging, Instantiation, and the Keyword Techniquehttps://youtu.be/TQdGaJDbzlg?si=tXJojRI3O3opR5Yz► SLA Insights #93: The Recycled Words Procedurehttps://youtu.be/TQdGaJDbzlg?si=UT2f2qjY6zRG16Q5► SLA Insights #94: Retelling Stories for Vocabulary Learninghttps://youtu.be/DNXA2lNZtiI?si=HZ9uRylFxcaP1aKV► SLA Insights #95: Three Resources for Teaching Biblical Hebrew Vocabularyhttps://youtu.be/vTPZg1hBUzgTogether, these episodes explore the complexity of knowing a vocabulary item, factors that encourage learning and retention, direct and indirect instruction, and practical activities that help move vocabulary into long-term memory.In the next SLA Insights series, Dr. Noonan will explore learner differences and what individual students bring to the process of second-language acquisition.Study deeper with GlossaHouse:

A four-month vacancy, a six-figure salary, and still no one to supervise your contrast scans. What if coverage gaps didn't require hiring anyone at all, on-site or on-call? Learn More at https://www.contrast-connect.com/blog-post/how-virtual-contrast-supervision-fills-physician-coverage-gaps-without-a-full-time-hire ContrastConnect City: Las Vegas Address: Las vegas Website: https://www.contrast-connect.com/

With so many treatment options for bladder outlet obstruction, how do you select the best approach for each patient? On this episode of BackTable Urology, host Dr. Jose Silva is joined by Dr. John DiBianco for a practical discussion on evaluating lower urinary tract symptoms and matching patients with the right intervention. They emphasize confirming that symptoms are truly due to benign prostatic hyperplasia (BPH) before proceeding, and walk through triggers for intervention, including quality-of-life impact, UTIs, renal impairment, high post-void residual, bladder stones, and retention. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 - Introduction03:24 - Complex BPH Referrals and Symptom Assessment06:07 - Deciding When to Operate11:12 - Imaging and Prostate Sizing14:27 - When to Use Cystoscopy and Urodynamics16:43 - Incorporating Patient Preferences21:53 - Medical Therapy and Pills23:45 - Decision Aids and Personal Experience27:13 - Managing HoLEP Complications and Leakage32:57 - Advances in HoLEP Technique36:07 - TURP Indications and Outcomes38:36 - Special Considerations: Radiation and UroLift39:58 - ThULEP vs. HoLEP41:17 - Redo Surgery Strategies43:52 - Counseling Through Case Scenarios56:16 - Future Directions in BPH Treatment59:05 - Wrap Up and Credits --- More about this episode The conversation covers everything from surveillance and imaging-based prostate sizing to when to use cystoscopy and urodynamics for complex or high-risk patients. Drs. Silva and DiBianco compare procedure options like HoLEP, TURP, GreenLight, UroLift, PAE, iTind, and aquablation, highlighting how factors like prostate size, morphology, history, and patient goals drive decision-making. They discuss durability, redo surgery issues, management of radiation patients, and postoperative care including leakage management and pelvic floor therapy. The episode wraps up with future directions in BPH procedures and practical counseling tips for patient satisfaction. --- Resources Love this episode? Check out BackTable.com and search “BPH” to get more information on a variety of the surgical options discussed in this episode, including HoLEP, Aquablation, PAE, and more! Further resources include the BackTable App, which has a course on treating Benign Prostatic Hyperplasia. --- BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

In this episode of HSS Presents, radiologist Dr. Harry G. Greditzer IV speaks with Dr. Hollis G. Potter, MD, Chair of Radiology and Imaging at Hospital for Special Surgery and holder of the Coleman Chair in MRI Research, about the evolution of musculoskeletal MRI and its transformative impact on orthopedic care. Together, they explore the early days of MRI at HSS, advances in cartilage imaging, metal artifact reduction, and innovations that have improved diagnostic accuracy and patient care. Dr. Potter also discusses the importance of collaboration between radiologists and surgeons, the role of mentorship in advancing the field, and how emerging technologies such as quantitative imaging and artificial intelligence may shape the future of musculoskeletal radiology, personalized treatment, and return-to-play decision-making.

Fathom said that it has over 400,000 monthly active users. Also, Glass Imaging was founded by a pair of former Apple engineers who previously led the team that developed Apple's Portrait Mode. And Cornelis, a company creating networking technology to help AI chips communicate more effectively, announced Monday that it has raised $205 million. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Commentary by Dr. Jian'an Wang.

The Final Podcast, the Future of Nuclear Medicine In this final podcast, I talk about what I see as the future of nuclear medicine. I talk about the key things, AI, Radiochemistry and new hardware.   To get in touch with me email me at nucmedpodcast@gmail.com Direct link to iTunes https://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2 Older podcasts https://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547 You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/. The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/ Please pass on information about this podcast to your colleagues and to your CPD provider.Link to VideoLink to Audio

The Final Podcast, the Future of Nuclear Medicine In this final podcast, I talk about what I see as the future of nuclear medicine. I talk about the key things AI, Radiochemistry and new hardware.   To get in touch with me email me at nucmedpodcast@gmail.com Direct link to iTunes https://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2 Older podcasts https://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547 You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/. The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/ Please pass on information about this podcast to your colleagues and to your CPD provider.Link to VideoLink to Audio

The Final Podcast, the Future of Nuclear Medicine In this final podcast, I talk about what I see as the future of nuclear medicine. I talk about the key things AI, Radiochemistry and new hardware.   To get in touch with me email me at nucmedpodcast@gmail.com Direct link to iTunes https://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2 Older podcasts https://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547 You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/. The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/ Please pass on information about this podcast to your colleagues and to your CPD provider.Link to VideoLink to Audio

The Final Podcast, the Future of Nuclear Medicine In this final podcast, I talk about what I see as the future of nuclear medicine. I talk about the key things, AI, Radiochemistry and new hardware.   To get in touch with me email me at nucmedpodcast@gmail.com Direct link to iTunes https://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2 Older podcasts https://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547 You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/. The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/ Please pass on information about this podcast to your colleagues and to your CPD provider.Link to VideoLink to Audio

The Final Podcast, the Future of Nuclear Medicine In this final podcast, I talk about what I see as the future of nuclear medicine. I talk about the key things, AI, Radiochemistry and new hardware.   To get in touch with me email me at nucmedpodcast@gmail.com Direct link to iTunes https://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2 Older podcasts https://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547 You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/. The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/ Please pass on information about this podcast to your colleagues and to your CPD provider.Link to VideoLink to Audio

Hosted by Rob Starks. The newest DESI Legacy Imaging Surveys map, 13 years in the making, covers three-quarters of the sky and catalogs nearly four billion objects. This treasure trove is available to all and contains stars, galaxies, supernovae, gravitational lenses, and much more. Two NSF NOIRLab facilities contributed data to the map: the U.S. National Science Foundation (NSF) Mayall telescope and the NSF Blanco telescope, equipped with the U.S. Department of Energy-fabricated DECam. In this podcast, Dr. John Moustakas discusses the surveys, the data and how it will impact future astronomical research.    Dr. John Moustakas is an associate professor of physics and the Department Chair in the Department of Physics & Astronomy at Siena University. His broad research interests are in observational cosmology and astrophysics, with a focus on using the most powerful telescopes on earth and in space to understand how galaxies have formed and evolved (changed) in a 14 billion-year universe which is dominated by dark matter. He is also interested in dark energy, the mysterious cosmic phenomenon which is causing the expansion rate of the universe to accelerate.   Rob Sparks is in the Communications, Education and Engagement group at NSF's NOIRLab in Tucson, Arizona.   We've added a new way to donate to 365 Days of Astronomy to support editing, hosting, and production costs.  Just visit: https://www.patreon.com/365DaysOfAstronomy and donate as much as you can! Share the podcast with your friends and send the Patreon link to them too!  Every bit helps! Thank you! ------------------------------------ Do go visit http://www.redbubble.com/people/CosmoQuestX/shop for cool Astronomy Cast and CosmoQuest t-shirts, coffee mugs and other awesomeness! http://cosmoquest.org/Donate This show is made possible through your donations.  Thank you! (Haven't donated? It's not too late! Just click!) ------------------------------------ The 365 Days of Astronomy Podcast is produced by the Planetary Science Institute. http://www.psi.edu Visit us on the web at 365DaysOfAstronomy.org or email us at info@365DaysOfAstronomy.org.

This week, Dr Sophie Ritson is in conversation with Professor Peter Galison, Joseph Pellegrino University Professor in History of Science and Physics at Harvard University, a founding member of the Black Hole Initiative, and coordinator of the History, Philosophy and Culture (HPC) Working Group of the next-generation Event Horizon Telescope (ngEHT).Galison is a historian and philosopher of science whose work has explored how experiments end, how scientific images are made and interpreted, and how practices of objectivity have developed. His books include How Experiments End, Image and Logic, Einstein's Clocks, Poincaré's Maps, and Objectivity (with Lorraine Daston). He also co-directed Secrecy and directed Black Holes: The Edge of All We Know, which follows the effort to produce the first image of a black hole.Sophie Ritson is a historian and philosopher of science at the University of Melbourne, and one of the leaders of the Collaborations focus group within the ngEHT's HPC Working Group. The group brings historians, philosophers, ethnographers and sociologists into a physics collaboration while it is still being built, rather than studying it retrospectively. Its work examines questions of governance and social epistemology, including authorship, consensus and disagreement. Ritson's own research has explored the string theory controversy, “non-discovery” in high-energy physics, and research governance, drawing closely on her engagement with physicists at CERN and the Large Hadron Collider.In this episode, Galison traces his path into the history and philosophy of science through family, teaching, and laboratory experience, emphasising how experimentalists taught him to distinguish effects from artefacts—a question that shaped his first book. He explains his interest in scientific images as a way of recovering the craft and tacit knowledge obscured by the protocol-driven view inherited from logical empiricism. The conversation then turns to the 2019 M87* image, which he presents as the culmination of his interest in secrecy and invisibility. The discussion concludes with broader questions about distributed knowledge, the state of HPS, and how to design billion-dollar instruments that remain open to the unexpected.This episode:Describes Galison's path into physics and the history of scienceExplains how distinguishing a real effect from an artefact shaped How Experiments EndIntroduces visualisation as a topic in HPS, against protocol-driven accounts of knowledgeDiscusses the materiality of science, and why the laboratory has looked like a church, a factory, and a startupFrames secrecy as "anti-epistemology," and how blocked knowledge illuminates how knowledge is securedArgues the black hole image is a computational image, and that photography is an expansive categoryReflects on the reconvergence of history and philosophy of science with contemporary practiceCloses on why images can surprise us, and how to design experiments open enough to find the unexpectedThis interview was recorded in July 2025.Relevant LinksPeter Galison, HarvardSophie RitsonngEHT History, Philosophy and Culture Working Group"Big STEM collaborations should include humanities and social science", Nature Human Behaviour (2023)A unique collaboration using a virtual Earth-sized telescope shows how science is changing in the 21st century, The ConversationThe HPC White Paper, Galaxies (2023)Black Holes | The Edge of All We Know (2020)Black Hole Initiative, Harvard UniversityEvent Horizon Telescope, first image, 10 April 2019Objectivity (Zone Books, 2007)How Experiments End (University of Chicago Press, 1987)S3 Ep 7, Sophie Ritson on 'Collaboration in Science' Episode production assistant: Paul CarterThanks for listening to The HPS Podcast. You can find more about us on our website, Bluesky, Instagram and Facebook feeds.  This podcast would not be possible without the support of School of Historical and Philosophical Studies at the University of Melbourne and the Hansen Little Public Humanities Grant scheme.Music by ComaStudio. Website HPS Podcast | hpsunimelb.org

Scientific Sense ® by Gill Eapen: Prof. Eric Betzig is a Professor of Molecular and Cell Biology and Chair in Experimental Physics, at the University of California, Berkeley. His interests include new imaging tools to aid in biological discovery, including correlative super-resolution fluorescence and electron microscopy, 4D dynamic imaging of living systems with non-diffracting light sheets, and adaptive optical microscopy to recover optimal imaging performance deep within aberrating multicellular specimens. In 2014, he was awarded the Nobel Prize in Chemistry for the development of super-resolved fluorescence microscopy Please subscribe to this channel: https://www.youtube.com/c/ScientificSense?sub_confirmation=1

Why do overuse injuries keep coming back even after the pain settles down? On this episode of BackTable Bone & Sports, Dr. Larry Balle welcomes Dr. Grant Ralston to define overuse injury as a load-related disorder, and to work through its causes, diagnosis, and management in both pediatric and adult athletes. They review common conditions like bone stress injuries, chronic tendinopathy, plantar fasciitis, and apophysitis, and discuss why year-round play, early sport specialization, social media, and name, image, and likeness (NIL) pressures are making these cases more frequent in clinic. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 - Introduction06:22 - Defining Overuse Injuries08:31 - Why Overuse Injuries Are Increasing15:33 - Corticosteroid Injections in Chronic Tendinopathy22:05 - Relative Rest and Cross-Training26:28 - Lower Extremity Overuse Injuries34:40 - Gluteal Tendinopathy and Greater Trochanteric Pain39:17 - Hydrodissection and Prolotherapy51:37 - Upper Extremity Overuse Injuries56:05 - Early Sport Specialization and Time Off01:00:39 - Training Load, Sleep, and Nutrition01:08:20 - Imaging, Physical Therapy, and Treatment Options01:15:40 - Final Takeaways and Wrap Up --- More about this episode The conversation moves through the lower and upper extremities, addressing Achilles tendinopathy, medial tibial stress syndrome, gluteal tendinopathy, patellofemoral pain, and rotator cuff tendinopathy, all with a focus on underlying biomechanical deficits. Drs. Ralston and Balle dissect the pros and cons of repeated corticosteroid injections, explore alternatives like ketorolac, prolotherapy, PRP, hydrodissection, and shockwave, and clarify when imaging should and shouldn't drive decisions. They close with tips on relative rest, scheduling breaks from sport, optimizing sleep and nutrition, and building strong referral networks to support patient recovery. --- Resources Fredericson M, et al. Tibial Stress Reaction in Runners: Correlation of Clinical Symptoms and Scintigraphy with a New Magnetic Resonance Imaging Grading System. Am J Sports Med. 1995 https://journals.sagepub.com/doi/10.1177/036354659502300418 Taheri P, et al. Comparison of Subacromial Ketorolac Injection versus Corticosteroid Injection in the Treatment of Shoulder Impingement Syndrome. J Res Pharm Pract. 2017 https://pubmed.ncbi.nlm.nih.gov/29417082/ --- BackTable Bone & Sports is the go-to podcast for orthopedic surgeons, sports medicine docs, pain specialists, and MSK radiologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

In this insightful episode of Parallax, Dr Ankur Kalra welcomes Dr Robert Riley, Director of Interventional Cardiology at Overlake Medical Center in Bellevue, Washington, for a masterclass on the contemporary management of complex PCI. Drawing on more than a decade of experience, Dr Riley explores how the field has evolved beyond technical success alone, with greater emphasis on patient selection, shared decision-making and aligning procedural goals with individual patient outcomes. The conversation takes a deep dive into the assessment and treatment of calcified coronary lesions, with a particular focus on the challenge of nodular calcium. Dr Riley shares his practical approach to intravascular imaging, lesion preparation and plaque modification, discussing when to utilise atherectomy, intravascular lithotripsy (IVL) and OPN balloons. He also highlights his growing use of drug-coated balloons in de novo lesions and provides insights into tailoring DAPT duration based on individual patient risk. For interventional cardiologists seeking actionable strategies to optimise outcomes in complex PCI, this episode offers invaluable clinical pearls from an experienced operator. How should operators approach heavily calcified lesions? When is atherectomy necessary, and where does IVL fit into modern practice? What role will drug-coated balloons play in the future of complex PCI? Questions and comments can be sent to "podcast@radcliffe-group.com" and may be answered by Ankur in the next episode. Host: @AnkurKalraMD and produced by: @RadcliffeCardio Parallax is Ranked in the Top 100 Health Science Podcasts by Million Podcasts.

CMS's permanent rule on virtual supervision is reshaping how imaging centers manage contrast procedures. Discover the compliance requirements, the role of real-time video coverage, and the potential operational benefits. Learn more at https://www.contrast-connect.com/blog-post/cms-contrast-supervision-2026-virtual-direct-supervision-authorized-as-permanent ContrastConnect City: Las Vegas Address: Las vegas Website: https://www.contrast-connect.com/

Send Audrey a Text to get your question answered on the showA four-year-old mare the vet diagnosied with synovitis, suspected bilateral upward fixation of the patella and normal radiographs and ultrasound. In this episode, Audrey explores how development, muscle capacity, hoof balance, inflammation and nutrition may contribute to a locking-stifle pattern even when imaging is unremarkable. She also discusses forage-based nutritional support, protein and mineral adequacy, flax versus preformed DHA, dried Schizochytrium microalgae and the importance of veterinarian-directed rehabilitation and collaborative care. Minerals and Metals Mane Test: https://equine-energy-medicine.myshopify.com/products/minerals-and-metals-mane-test?variant=66748496150832Find all the resources listed here: linktr.ee/equineenergymedAudrey is not an MD or DVM and has never implied or claimed to be either. Audrey holds a Doctoral Degree in Traditional Naturopathy and a Master's Degree in Science. She created an evidence-based anti-inflammatory nutrition program for equines and has successfully helped over 10k horses with a balanced anti-inflammatory forage diet. This information is non-medical in nature and is not meant to diagnose, prescribe for, treat, or cure, and is not a replacement for your veterinarian.  These are my personal interpretations based on my education, skills, and experience. Equine Energy Medicine refers to non-invasive, supportive modalities focused on energetic balance, nutrition, and overall well-being, and does not replace veterinary care.

Links & sources Brown University — LZ experiment sees surprising result in search for dark matter — https://www.brown.edu/news/2026-09-01/lz-dark-matter-results US Department of Energy — LZ Sees Surprising Result in Search for Dark Matter — https://www.energy.gov/science/articles/lz-sees-surprising-result-search-dark-matter Imperial College London — Dark matter hunt takes unexpected turn after puzzling signal spotted in LZ detector — https://www.imperial.ac.uk/news/articles/natural-sciences/physics/2026/dark-matter-hunt-takes-unexpected-turn-after-puzzling-signal-spotted-in-lz-detector/ TeVPA 2026 — Search for high-energy dark matter interactions with the LUX-ZEPLIN experiment — https://indico-icehap.phys.s.chiba-u.ac.jp/event/3/contributions/471/ The LZ Dark Matter Experiment — collaboration site — https://lz.lbl.gov/ Space.com — Scientists may have detected the 1st direct evidence of dark matter — https://www.space.com/astronomy/dark-universe/scientists-may-have-detected-the-1st-direct-evidence-of-dark-matter ARC Centre of Excellence for Dark Matter Particle Physics — Stawell Underground Physics Laboratory — https://www.centredarkmatter.org/supl SABRE South — dark matter direct-detection experiment — https://www.sabre-experiment.org.au/ Phys.org — Underground lab clears crucial hurdle for dark matter hunt — https://phys.org/news/2026-04-underground-lab-crucial-hurdle-dark.html Space.com — India sends Earth-imaging satellite toward geosynchronous orbit in milestone launch — https://www.space.com/space-exploration/launches-spacecraft/gslv-mark-ii-eos-05-launch-first-indian-geo-earth-observing-satellite Outlook India — 'Successfully and precisely injected': ISRO chairman hails GSLV-F17 launch — https://www.outlookindia.com/national/successfully-and-precisely-injected-isro-chairman-hails-gslv-f17-launch-eos-05-reaches-orbit Business Standard — ISRO launches India's first imaging satellite in geostationary orbit — https://www.business-standard.com/india-news/isro-launches-india-s-first-imaging-satellite-in-geostationary-orbit-126090400054_1.html Space.com — Rocket issues delay 1st-ever private mission to Venus — https://www.space.com/astronomy/venus/rocket-issues-delay-1st-ever-private-mission-to-venus-we-are-awaiting-neutron-readiness Syracuse University — The Spin Behind Fading Black Hole Flares — https://news.syr.edu/2026/09/01/the-spin-behind-fading-black-hole-flares/ arXiv — The Role of Stellar Spin in Repeating Partial Tidal Disruption Events (2606.02692) — https://arxiv.org/abs/2606.02692 NASA Science — What's Up: September 2026 Skywatching Tips — https://science.nasa.gov/solar-system/skywatching/whats-up-september-2026-skywatching-tips-from-nasa/ Universe Today — Lunar occultations of Jupiter, Venus and more in September — https://www.universetoday.com/articles/penultimate-lunar-occultations-inbound-for-jupiter-venus-and-more-in-september In-The-Sky.org — Lunar occultation of Jupiter, 8 September 2026 — https://in-the-sky.org/news.php?id=20260908_16_100 EarthSky — Sun news: flare, CME and aurora updates — https://earthsky.org/sun/sun-news-activity-solar-flare-cme-aurora-updates/ Space.com — Night sky September 2026: the best things to see this month — https://www.space.com/stargazing/what-to-see-night-sky-september-2026 Follow us: @AstroDailyPod · astronomydaily.ioBecome a supporter of this podcast: https://www.spreaker.com/podcast/astronomy-daily-latest-space-news--5648921/support.Sponsor Details:Ensure your online privacy by using NordVPN. To get our special listener deal and save a lot of money, visit www.astronomydaily.io/nordvpn. You'll be glad you did!Get the best secure and private email on the planet. Stop your Government, google and who knows who else spying on every email you write. Do what we did and use ProtonMail. They beleive in privacy and there are no ads in their business model...yet they still provide a free forever service. Check them out and get out special deal at www.astronomydaily.io/protonmailBecome a supporter of Astronomy Daily by joining our Supporters Club. Commercial free episodes daily are only a click way... Click HereThis episode includes AI-generated content.

Most drug discovery genomic data comes from a thin slice of the world, and that bias follows every decision downstream. Your team can run a Mendelian randomization study on 35,000 patients and still walk away with a single signal that doesn't even apply to the population you care about. If your phenotype definitions are fuzzy, more data won't save you. Erika Kvikstad is a computational biologist who led precision medicine for cardiovascular disease at Bristol-Myers Squibb, working on therapies including Camzyos for hypertrophic cardiomyopathy. She now works independently on genomic data equity, focused on how reference populations shape everything from target discovery to clinical trial recruitment. You'll get a practical look at how to evaluate real-world data vendors, why heart failure is nearly impossible to define cleanly from billing codes, and where statistical power breaks down even with tens of thousands of patients. Erika also explains how her team used AI to reconstruct missing imaging data and validate cardiomyopathy diagnoses at scale. This episode covers GWAS studies, Mendelian randomization, UK Biobank, proteome-wide analysis, and the practical gap between biobank-scale data and disease-specific cohorts. It's built for data and analytics leaders working in life sciences who need to understand where genomic bias enters their pipeline, not just that it exists. Clarification Around 57:58–58:24, in discussing the proteome-wide Mendelian randomization study, Erika moved quickly between two related findings. BTN3A2 was identified as a candidate associated with ischemic stroke and potential immune-modulatory biology. Separately, single-cell expression data helped contextualize other candidate signals, including some with enriched expression in cardiomyocyte populations. Cardiomyocyte-enriched expression was not a specific finding for BTN3A2. Chapter Markers 00:00 Whose genome are we designing drugs for 01:34 Erika's path from academic genomics to BMS 03:48 Building the precision medicine strategy at BMS 06:37 Ross shares his own HCM diagnosis 07:09 Why heart failure resists clean definition 11:11 How medication use reclassifies patients 14:35 Imaging as a biomarker, and its data gaps 20:23 Data infrastructure gaps across regions 22:44 What to look for when evaluating a data vendor 27:35 Consortia and biobanked specimens for rare mutations 29:52 Cardiovascular data infrastructure versus oncology 32:29 Where statistical power breaks down 37:07 UK Biobank's strengths and its limits 40:01 Bridging broad biobanks with disease-specific cohorts 44:32 How reference population bias propagates downstream 48:53 Where genomic bias hits hardest in the pipeline 53:18 Inside a proteome-wide Mendelian randomization study 59:42 Choosing the right computational tool for the question 1:06:38 Building globally representative genomic infrastructure 1:08:04 Ross's takeaways on bias and statistical power Useful Links & Resources - Erika on LinkedIn: https://www.linkedin.com/in/erikakvikstad - UK Biobank: https://www.ukbiobank.ac.uk - Alliance for Genomic Discovery: https://alliancegenomicdiscovery.org - SHaRe Registry (DCM Foundation): https://dcmfoundation.org Connect With the Show - Ross Katz on LinkedIn: https://www.linkedin.com/in/b-ross-katz/ - (Ross Katz on X: https://x.com/brosskatz - CorrDyn LinkedIn: https://www.linkedin.com/company/corrdyn/ Have you run into genomic reference bias in your own work? Tell us what it looked like and how your team caught it. Visit corrdyn.com to learn how CorrDyn can help your organization extract value from data. Subscribe to Data in Biotech so you don't miss the next conversation.

Drs. Montesi and Martinez discuss how the emerging PRIME-PPF clinical cohort study and biomarker research will sharpen definitions of disease progression and transform treatment decisions in non-IPF ILD. They highlight the potential for clinicians to use integrated data (eg, symptoms, physiology, imaging, and circulating proteomic signatures) to initiate antifibrotic and combination therapies earlier, tailoring them to individual patients while also balancing side effects and standard immunomodulatory care.

Welcome to this week's Midlife Minute episode! Statistically, one in three women will die of heart disease. So, today, we're answering some of the many questions I received about lipids and heart health. Although I've done other lipid-focused Midlife Minutes before, this episode is yet another dedicated to Dr. Tom Dayspring, as I've received such a vast number of questions on this particular topic.    IN THIS EPISODE, YOU WILL LEARN: Why understanding your ApoB and Lp(a) is an essential part of assessing your cardiovascular risk Why treatments for lipid abnormalities should be individualized to fit each specific abnormality  Essential lifestyle measures for supporting overall cardiovascular health How CAC scoring, CT coronary angiography, and Clearly AI-assisted imaging differ, what each test measures, and their limitations  How cardiovascular disease can sometimes present differently in women  Why are premature atrial contractions and premature ventricular contractions often benign when the heart is structurally normal? How the roles of statins, ezetimibe, PCSK9 inhibitors, GLP-1 medications, and emerging RNA therapies differ, and why they should not be considered interchangeable How declining estrogen impacts cardiovascular health Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website. Submit your questions to support@cynthiathurlow.com  Join other like-minded women in a supportive, nurturing community: The Midlife Pause/Cynthia Thurlow.  Purchase Cynthia's book, The Menopause Gut. Cynthia's Intermittent Fasting Transformation Book The Midlife Pause Supplement Line

What does it take for a 45-year-old association to continually reinvent itself in a field being transformed by digitization and AI? And how can an association bring together professionals from different specialties, roles, and organizations to help shape the future of an entire field?In this episode of Associations Thrive, host Joanna Pineda interviews Cheryl Kreider Carey, CAE, CEO of the Society for Imaging Informatics in Medicine (SIIM). Cheryl discusses:How imaging informatics sits at the intersection of medical imaging, digital health, and technology management.How SIIM membership grew by more than 20% in 2025 as the association expands its reach across imaging specialties.How SIIM's nearly 3,000 members represent five different personas, including clinicians across imaging specialties, scientists, developers, vendors, and imaging IT experts.How the organization's ethos, “You Belong at SIIM,” reflects its commitment to bringing these different communities together.Why Cheryl describes SIIM as a “45-year-old startup.” The organization has reinvented itself as medical imaging evolved from film to digital and has had three different names over its 45-year history.How Cheryl works to create what she calls an “invisible culture,” inspired by successful sports coaches who build team chemistry that ultimately produces visible results. At SIIM, she describes the culture as “high emotional intelligence, low ego.”How SIIM partnered with the Digital Pathology Association to create a Bridge Pass: one streamlined payment that allows participants to attend both SIIM's annual conference and the Pathology Visions Conference.How SIIM has been ahead of the curve on artificial intelligence, holding its first AI conference in 2017 and continuing to convene professionals around AI ever since.References:SIIM WebsiteBridge Pass Program

In this encore episode, Dr. Liew shares her personal journey to becoming a rheumatologist inspired by a friend's diagnosis. She then discusses the condition in detail, addressing common misconceptions such as it being exclusive to white men and always showing up on imaging. Listeners will gain invaluable insights into the challenges of diagnosing this condition, social determinants affecting diagnosis, and reliable resources for further information. This episode is a must-listen for anyone navigating the labyrinth of rheumatic diseases, providing hope and knowledge to help you thrive. Episode at a glance: 00:00 Introduction to Rheumer Has It Podcast 00:26 Meet Dr. Jean Liew: Expert on Axial Spondyloarthritis 00:40 Understanding Axial Spondyloarthritis 01:41 Dr. Liew's Journey into Rheumatology 04:16 Busting Myths: Axial Spondyloarthritis and Demographics (it's not just men!) 06:50 Challenges in Diagnosing Axial Spondyloarthritis 10:27 The Role of HLAB 27 in Axial Spondyloarthritis 12:26 Imaging and Axial Spondyloarthritis 14:38 Final Thoughts and Resources Medical disclaimer: All content found on Arthritis Life public channels (including Rheumer Has It) was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Episode Sponsors Rheum to THRIVE, an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

When to image, when to wait, and what to do when the ideal test isn't available are often far more nuanced than they appear. In this EM Cases episode, Dr. Amit Shah joins Anton to tackle some of the toughest everyday imaging decisions: How much should cumulative radiation exposure influence our decision to order another CT? In suspected appendicitis, when is it safe to wait for ultrasound rather than obtain CT overnight? Can the emerging traumatic brain injury biomarkers GFAP and UCH-L1 help avoid CT, particularly in rural and remote settings? And in suspected cauda equina syndrome, how can PVR and CT lumbar spine be combined to risk-stratify patients when MRI isn't immediately available—and when should a reassuring PVR or CT not reassure us? Plus, practical shared decision-making strategies, the role of the “tincture of time,” and much more... Please consider a donation to EM Cases to support ongoing high-quality Free Open Access Medical Education: https://emergencymedicinecases.com/donation/

Trauma imaging has never been more accessible, and the pan‑scan often feels like the fastest path to certainty. In this edition of our resident journal club, join Drs Gallen and Vaughn as they pair and review two articles regarding trauma CT utilization - REACT-2 and Ather et al, with a hope of exploring the question of when whole-body CT improves care vs when selective imaging can be equally as effective.

CardioNerds (Drs. Dr. Natalie Marrero, Dr. Ritika Tuli, and Dr. Rafael Toro Manotas) discuss multimodality imaging for risk stratification, evaluation, and management of chronic coronary artery disease with Dr. Panithaya Chareonthaitawee. Audio editing by CardioNerds intern Iman Razeghian. This episode was produced as part of the CardioNerds Academy curriculum by House Taussig under the guidance of House Chief, Dr. Natalie Marrero and Academy Program Director, Dr. Gurleen Kaur. A matching review article will be published in US Cardiology Review, the official journal of CardioNerds. This discussion was planned in collaboration with the Mayo Clinic Cardiovascular Board Review Course. In this episode, we discuss the pathophysiology and risk stratification of chronic coronary artery disease (CAD), as well as the current landscape of non-invasive evaluation of this condition. CAD remains a leading cause of morbidity and mortality despite advances in pharmacological and non-pharmacological strategies for the prevention and treatment of atherosclerotic disease. The concept of chronic CAD has shifted from the traditional model of stable, obstructive, flow-limiting disease, toward the current understanding of a dynamic process that extends beyond obstructive epicardial lesions to include non-obstructive plaque, diffuse atherosclerosis, and microvascular disease. Similarly, the imaging modalities used to evaluate CAD have evolved, and clinicians now have an extensive menu of options, each with distinct advantages and limitations, that must be selected carefully to maximize diagnostic accuracy and optimize treatment guidance, while also considering resource availability, local expertise, and high-value care. By the end of the episode, listeners will understand the pathophysiology of chronic CAD, risk-stratify patients with suspected CAD, recognize the advantages and pitfalls of each non-invasive diagnostic modality, and select the most appropriate diagnostic tool for a given clinical scenario. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. CardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls: Chronic CAD is a complex process that extends beyond obstructive epicardial stenosis to include non-obstructive disease, dynamic plaque burden and ischemia, diffuse atherosclerosis, microvascular dysfunction, vasospasm, among others. When evaluating patients with suspected CAD, the diagnostic process should be guided by a specific and appropriate clinical question before ordering any tests. The current diagnostic tool arsenal is broadly divided into anatomic and functional imaging modalities. These are complementary, each with distinct properties and limitations, addressing different clinical questions and assessing different aspects of disease. Local availability and expertise, along with patient-specific considerations and contraindications, determine the choice of diagnostic modality. No single test is best for every patient. INOCA and coronary microvascular dysfunction represent a common and increasingly recognized entity that is diagnosable and treatable; initial evaluation includes non-invasive testing such as stress PET and stress CMR. References Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;144(22):e368-e454. doi:10.1161/CIR.0000000000001029 https://pubmed.ncbi.nlm.nih.gov/34709879/ Vrints C, Andreotti F, Koskinas KC, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45(36):3415-3537. doi:10.1093/eurheartj/ehae177 https://pubmed.ncbi.nlm.nih.gov/39210710/ Virani SS, Newby LK, Arnold SV, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023;148(9):e9-e119. doi:10.1161/CIR.0000000000001168 https://pubmed.ncbi.nlm.nih.gov/37471501/ Edvardsen T, Asch FM, Davidson B, et al. Non-Invasive Imaging in Coronary Syndromes: Recommendations of The European Association of Cardiovascular Imaging and the American Society of Echocardiography, in Collaboration with The American Society of Nuclear Cardiology, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2022;35(4):329-354. doi:10.1016/j.echo.2021.12.012 https://pubmed.ncbi.nlm.nih.gov/35379446/ Douglas PS, Hoffmann U, Patel MR, et al. Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med. 2015;372(14):1291-1300. doi:10.1056/NEJMoa1415516 https://pubmed.ncbi.nlm.nih.gov/39210710/ Sharma A, Coles A, Sekaran NK, et al. Stress Testing Versus CT Angiography in Patients With Diabetes and Suspected Coronary Artery Disease. J Am Coll Cardiol. 2019;73(8):893-902. doi:10.1016/j.jacc.2018.11.056 https://pubmed.ncbi.nlm.nih.gov/30819356/ SCOT-HEART Investigators, Newby DE, Adamson PD, et al. Coronary CT Angiography and 5-Year Risk of Myocardial Infarction. N Engl J Med. 2018;379(10):924-933. doi:10.1056/NEJMoa1805971 https://pubmed.ncbi.nlm.nih.gov/30145934/ Li Z, Xu T, Wang Z, et al. Prognostic Significance of Computed Tomography-Derived Fractional Flow Reserve for Long-Term Outcomes in Individuals With Coronary Artery Disease. J Am Heart Assoc. 2025;14(2):e037988. doi:10.1161/JAHA.124.037988 https://pubmed.ncbi.nlm.nih.gov/39791423/ Bateman TM, Al-Mallah MH, et al. Clinical indications for positron emission tomography myocardial perfusion imaging and myocardial blood flow quantification: An American Society of Nuclear Cardiology position statement. J Nucl Cardiol. 2026;57:102619. doi:10.1016/j.nuclcard.2025.102619 https://pubmed.ncbi.nlm.nih.gov/41482140/ Taqueti VR, Di Carli MF. Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018;72(21):2625-2641. doi:10.1016/j.jacc.2018.09.042 https://pubmed.ncbi.nlm.nih.gov/30466521/ Taqueti VR, Hachamovitch R, Murthy VL, et al. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation. 2015;131(1):19-27. doi:10.1161/CIRCULATIONAHA.114.011939 https://pubmed.ncbi.nlm.nih.gov/25400060/ Mehta PK, Huang J, Levit RD, Malas W, Waheed N, Bairey Merz CN. Ischemia and no obstructive coronary arteries (INOCA): A narrative review. Atherosclerosis. 2022;363:8-21. doi:10.1016/j.atherosclerosis.2022.11.009 https://pubmed.ncbi.nlm.nih.gov/36423427/ Kunadian V, Chieffo A, Camici PG, et al. An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. EuroIntervention. 2021;16(13):1049-1069. doi:10.4244/EIJY20M07_01 https://pubmed.ncbi.nlm.nih.gov/32624456/